Echothiophate eye drops for children with stubborn amblyopia
Part of Brain & nervous system, Eyes & vision clinical trials.
This study tests whether a medicine called echothiophate, given as eye drops, can improve vision in children whose amblyopia (lazy eye) has stopped improving with standard atropine treatment. The goal is to see if this new approach can help children see better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 3 and 18 years old.
- You have amblyopia (lazy eye) that has not improved with atropine eye drops.
- Your vision in the weaker eye is between 20/40 and 20/100, and your stronger eye sees 20/30 or better.
- You have had an eye exam to check your glasses prescription within the last 6 months.
- You are currently using atropine eye drops at least twice a week.
- You do not have other eye conditions like cataracts, scars, or droopy eyelids that could affect the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests eye drops to improve how a child’s eyes line up and how well they can use both eyes together. It may help children with certain types of outward eye drifting (intermittent exotropia/exophoria).
This trial tests whether atropine eye drops can reduce the progression of myopia (nearsightedness, where you have trouble seeing far away) in children. It might help slow down the worsening of vision over time.
This trial tests a new treatment for children aged 8 to 12 with lazy eye (amblyopia) who have stopped standard treatments. The goal is to see if this therapy can improve vision in the weaker eye.
This trial tests whether a combination of low-dose atropine eye drops (0.02% or 0.04%) and special glasses (called DIMS) can slow down the worsening of moderate to high myopia in children aged 6 to 12.
This trial tests whether daily atropine eye drops can slow down worsening nearsightedness in children. It's for kids aged 5–10 whose myopia is actively progressing.
This study tests whether low-dose atropine eye drops can prevent nearsightedness (myopia) in children. Atropine is a medicine that has been used to slow myopia, and this trial looks at gradually increasing the dose to find the best approach.
Hear when a new Refractory Amblyopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.